Remodulin

United Therapeutics Corporation🇺🇸 United States

FDA Page

Effective Date: Jul 2, 2026
Approval ID: 6c80bb38-e8db-4138-9f0d-dbbf9c673185
Products: 9 registered
Version: 35

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use REMODULIN safely and effectively. See full prescribing information for REMODULIN. REMODULIN (treprostinil) Injection, for subcutaneous or intravenous use Initial U.S. Approval: May 2002

Quick Stats

Total Products9

Labelers2

Label Sections25

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.